| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXEL | Common Stock | Sale | $103,774 | -4,717 | -0.76% | $22.00 | 618,519 | 28 Mar 2022 | Direct | F1, F2 |
| transaction | EXEL | Common Stock | Sale | $292,226 | -13,283 | -2.1% | $22.00 | 605,236 | 29 Mar 2022 | Direct | F1 |
| holding | EXEL | Common Stock | 999 | 28 Mar 2022 | By 401(k) | F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2020. |
| F2 | Includes 144,482 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |
| F3 | Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of March 28, 2022. |